關於 cookie 的說明

本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗,我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示,便表示您已接受我們的網站使用條款。

搜尋結果Search Result

符合「investors」新聞搜尋結果, 共 6340 篇 ,以下為 4393 - 4416 篇 訂閱此列表,掌握最新動態
TigerGPT Maximizes Pre-investment Preparation Efficiencies with New Features in Official Launch

TigerGPT is now available to users in markets including New Zealand, Australia, Singapore and Hong Kong. The latest version introduces innovative features that allow investors to swiftly research stocks, summarize key insights from earning calls and releases, and extract pertinent company news based on sentiment analysis, all within seconds. This release signifies a significant advancement in Tiger's efforts to enhance efficiency in pre-investment preparation for investors. SINGAPORE, July 26, 2023 /PRNewswire/ -- TigerGPT, an AI-powered chatbot developed among Tiger Brokers' vast internet services, officially launches today after successful beta testing since April. As part of this launch, TigerGPT introduces a suite of new features to streamline the process of pre-investment preparation, including personalized stock research that enables investors to quickly filter stocks based on their own criteria, as well as showing trending market topics to help investors to pinpoint the trends in the market. Instead of spending time navigating multiple news sources, TigerGPT assists investors in extracting company news and performing sentiment analysis to classify them as positive or negative. Another key feature is the ability to summarize highlights from earning calls and releases, offering investors a comprehensive overview of a company's performance at a glance. Leveraging Tiger Trade's access to premium data and research, TigerGPT also adds data including support and resistance indicators, stock trend analysis, and economic calendars, expanding its capabilities to address a wider range of inquiries effectively. "We recognize the crucial role AI plays in the investment industry today and its potential for future growth, which is why we developed TigerGPT — to revolutionize the investor experience on a larger scale. Users no longer need to rely solely on keyword searches or sift through vast amounts of information to find relevant and concise content, which can be time-consuming. With TigerGPT as their AI investment companion, users can now enjoy a whole new dimension of interactive experience, empowering them to make more informed and intuitive investment decisions," said Wu Tianhua, founder and CEO of Tiger Brokers. Furthermore, TigerGPT now offers multi-turn conversations, enabling the chatbot to remember previous user inputs and provide meaningful responses based on the ongoing conversation. Additionally, TigerGPT is seamlessly integrated into Tiger Trade's individual stock page, appearing as a pop-up notification when unusual stock activities or significant events are detected. Building on its commitment to innovation, the TigerGPT team continually enhances the chatbot on a weekly basis to ensure a seamless and optimized user experience. The full version of TigerGPT is now accessible to users in markets including New Zealand, Australia, Singapore and Hong Kong. In conjunction with the official launch, users can now participate in TigerGPT activities through the Tiger Trade App. By accessing the "AI Insights for Earnings Season" page within the app, users can engage with TigerGPT by asking questions and have the opportunity to win rewards such as US stock vouchers. Additionally, by posting on Tiger Community and tagging @TigerGPT, users can earn Tiger Coins, which can be redeemed for exclusive gifts and privileges. These activities will be available until October 17, 2023. Please note that the information provided by TigerGPT is for reference only, and should not be treated as financial advice. Tiger Brokers shall not be liable in any way in connection with the use of TigerGPT. TigerGPT does not provide any recommendation, all information provided is from the open data source. About TigerGPT TigerGPT is a text-generating AI chatbot developed among the internet services of Tiger Brokers (Nasdaq: TIGR), as the first deployment of AI investment assistant in the brokerage industry. TigerGPT leverages the company's vast financial content pool and OpenAI technology. The feature leverages Tiger Brokers' vast content library and its expansive access to paid sources to offer timely and informative responses, including but not limited to, listed companies' profiles and data, an ocean of financial knowledge and investor education materials, and market and stock insights, in a response to users' investment-related queries in easily digestible conversations within a span of seconds, saving time spent on market research and raising efficiency in pre-investment preparation. Tiger Brokers is a leading online brokerage firm founded in 2014 with a focus on redefining global investing with technologies for the next generation. Currently, we offer a multitude of quality financial products and services across brokerage, employee stock ownership plan (ESOP) management, investment banking, wealth management, investor community, and investor education. For inquiries, please contact press@itiger.com.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 639 加入收藏 :
Moomoo Extends Charting Feature to Mobile Users, Gains the First US Utility Patent

PALO ALTO, Calif., July 26, 2023 /PRNewswire/ -- Moomoo users now have a novel charting feature available at their fingertips. Moomoo's Research & Development affiliate has secured a patent for a new method that investors can use to draw and customize charts. This patented feature complements the 38 drawing tools and more than 60 investing indicators available through our services. The automatic line- drawing feature is now also available to U.S. mobile users along with a proprietary self- developed algorithm, which can recognize daily stock data patterns. The new patent (US 11,656,750 B2), authorized by the U.S. Patent and Trademark Office, highlights moomoo's commitment to utility innovation and is an essential avenue to further provide users with outstanding product features and services. "Moomoo is devoted to developing and bringing to market technology that allows retail traders to compete on a level playing field with institutional market participants. This charting feature is an example of one of the unique tools and features offered on the moomoo app that aids its users in their investing journey," said Justin Zacks, Vice President of Strategy for Moomoo Technologies Inc. Moomoo has long advocated and implemented technology innovations related to stock market trading opportunities. With real-time data that refreshes every 0.03 seconds, users can draw a variety of charts to that can help them discover potential trading opportunities or customize technical indicators to optimize their investment decisions. About Moomoo Moomoo is an investment and trading platform that empowers global investors with pro- grade, easy-to-use tools, data, and insights. It provides users with the necessary information advanced charting tools, technical analytics, and Level 2 Data. Moomoo grows with its users, cultivating a community where investors share, learn, and grow together in one place. Moomoo provides free access to investment courses, educational materials, and interactive events that any investor, at any level, can gain from. Users can join forum discussions, trending topics, and seminars to help their investment knowledge and insights. Moomoo is not just your investment platform. It is your investment journey. For more information, please visit moomoo's official website at www.moomoo.com or contact moomoo's public relations team via pr@us.moomoo.com.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 1390 加入收藏 :
AdTheorent Awarded Frost & Sullivan's 2023 North American Product Leadership Award for Its Groundbreaking Audience Targeting Solutions

AdTheorent is an industry-leading company that delivers customized machine learning and powerful data science advertising solutions to global enterprises. SAN ANTONIO, July 25, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the digital advertising industry and, based on its findings, recognizes AdTheorent (Nasdaq: ADTH), with the 2023 North American Product Leadership Award. AdTheorent is a disruptive machine learning (ML) platform for cross-channel advertising that offers predictive targeting to drive advertiser outcomes and maximize return on investment (ROI). AdTheorent is the only seven-time recipient of this recognition since Frost & Sullivan began its Best Practices Award Recognition in 2001. AdTheorent developed the first machine learning-based demand-side platform (DSP) to offer statistics-based targeting that streamlines the user experience (UX) and dramatically increases customers' chances of success. The company's innovative ML-DSP leverages ML and artificial intelligence (AI) algorithms to target each client's unique audience and deliver highly personalized advertising campaigns, harnessing data-driven predictive analytics to drive successful business outcomes. The company's machine learning engine analyzes vast amounts of data (reflecting a vast and impressive investment in programmatic data augmentation, curation, and normalization) and forecasts the likelihood of ad engagement and conversion at the individual ad impression and campaign KPI level. Leveraging ML, AdTheorent predicts and scores the probability of a successful outcome; highly integrated feedback loops tied to campaign outcomes train ML models in real-time, making them smarter iteratively, and building a constant improvement cycle allowing AdTheorent to ensure that each ad will reach target users at the right time. With a customer-centric approach and a corporate culture that revolves around purpose-driven innovation, AdTheorent stays ahead of the curve while meeting customers' ever-evolving needs. This pioneering strategic vision has led AdTheorent to generate superior solutions that enable its clients to have outstanding capabilities in their advertising campaigns. "Backed by its 11+ years of industry-leading expertise, the company's solutions advance digital advertising one step further than competing solutions. Unlike the alternatives, AdTheorent's open-ended system is data agnostic and does not rely on user profiles, user IDs or cookie pools," said Alaa Saayed, Senior Program Director at Frost & Sullivan. AdTheorent continuously evolves and enhances its existing portfolio to ensure optimal performance. For example, the company launched a groundbreaking new audience targeting solution built using AdTheorent's audience builder, ABi™, and a health-specific product, AdTheorent's Health Audience Builder, or HABi™. ABi and HABi facilitate the development of algorithms that are designed to ensure that ads are served only to users who belong to a desired customer-specified audience and are most likely to take a desired campaign action. The AdTheorent team uses ABi and HABi to build and activate audiences for managed service customers.  In the third quarter, customers will be able to utilize ABi or HABi to build AdTheorent Predictive audiences within AdTheorent's self-service platform. Using these platforms, customers can automate their preferences and targets using transparent and highly reliable data sources. Without utilizing cookies, IDs, or personally identifiable information, ABi and HABi deliver superior audience quality and KPI performance. Recently, the company was certified by an industry third party for its Predictive Audiences, providing independent verification of data quality. To earn this validation AdTheorent submitted to an independent data audit, demonstrating that AdTheorent Predictive Audiences maintain the highest standards of data quality, privacy, and transparency. AdTheorent is strongly committed to keeping its customers' privacy protected. The company's ad targeting is not dependent on third-party data licenses, cookies, device identifiers, or unified or individualized identifiers. As a result, AdTheorent does not store any sensitive or personal data, which is advantageous for regulated industries, such as banking, finance, and healthcare. AdTheorent's next innovation is its Health DSP, launching for self-service users in the third quarter of 2023, which the company has referred to as its most ambitious product launch to date, and the industry's most advanced privacy-forward health marketing research and patient targeting solution. "AdTheorent's distinctive approach to digital advertising prioritizes privacy concerns and has high-quality design, reliability, and quality as its central pillars. Its privacy-forward strategy and capacity to deliver sophisticated business outcomes for advertisers distinguish the company from competitors," noted Valentina Barcia, Best Practices Analyst at Frost & Sullivan. Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid market acceptance. The award recognizes the quality of the solution and the customer value enhancements it enables. Frost & Sullivan Best Practices Awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. About AdTheorent  AdTheorent (Nasdaq: ADTH) uses advanced machine learning technology and privacy-forward solutions to deliver impactful advertising campaigns for marketers. AdTheorent's machine learning-powered media buying platform powers its predictive targeting, predictive audiences, geo-intelligence, audience extension solutions and in-house creative capability, Studio A\T. Leveraging only non-sensitive data and focused on the predictive value of machine learning models, AdTheorent's product suite and flexible transaction models allow advertisers to identify the most qualified potential consumers coupled with the optimal creative experience to deliver superior results, measured by each advertiser's real-world business goals.  AdTheorent is consistently recognized with numerous technology, product, growth and workplace awards. Additionally, AdTheorent is the only seven-time recipient of Frost & Sullivan's "Digital Advertising Leadership Award." AdTheorent is headquartered in New York, with fourteen offices across the United States and Canada.  For more information, visit adtheorent.com. Contact: Ashley WeinkaufP: 210-844-2505E: ashley.weinkauf@frost.com  Melanie Berger. AdTheorentP: 850-567-0082E: melanie@adtheorent.com 

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 578 加入收藏 :
GEODIS India celebrates 25 years of delivering Innovative, Sustainable and Ethical Logistics Solutions

NEW DELHI, INDIA - Media OutReach - 25 July 2023 - GEODIS, a world leader in transport and logistics, celebrates its 25th anniversary in India. Since 1998, GEODIS has invested in India's entrepreneurial and burgeoning economy in order to support its clients from a wide range of business sectors, including automotive, FMCG, healthcare, high technology, industrial and retail. Today, it continues such investment due to the country's immense growth potential and strategic role in businesses' supply chains. India plays a vital role in the strategy of GEODIS' APAC due to its status as one of the fastest-growing economies in the world and as companies increasingly shift their manufacturing and sourcing to the country. Its immense growth potential, strategic geographical location, and its ability to serve as a crucial hub for GEODIS' APAC operations enables the company to better meet its customers' needs. The company recently invested in a multi-user facility in Luhari to seize the strong growth opportunities in India's retail business with advanced warehousing solutions to support e-commerce. The state-of-the-art facility incorporates market leading sustainability and environmental initiatives including 20 acres of Miyawaki Forest Plantation, solar power generation and distribution for warehouse and common infrastructure energy provision, in line with GEODIS' commitment to care for the environment. Yet more recently, GEODIS established its Centre of Excellence (CoE), its sixth strategic control tower for its Supply Chain Optimization Line of Business in Bangalore. The CoE specializes in supply chain management and advisory. Bangalore was chosen primarily for the availability of a critical mass of talented supply chain specialists. The new control tower operates with 60 supply chain experts to provide customers with end-to-end visibility, performance monitoring and continuous improvement to supply chain processes on a 365/7/24 multilingual basis. GEODIS ensures the highest level of service, quality and compliance in international supply chain management for its customers. GEODIS has attained certifications, such as the Investors in People accreditation, IATA CEIV Pharma and AEO by the Indian Customs. Harpreet Singh, Sub-Regional Managing Director, South Asia, GEODIS, said, "We are honored to celebrate this milestone and proud of the achievements we have made in India over the past 25 years. We would like to thank our employees, customers and partners who have been instrumental in driving our success and growth in this region. Today, we serve 7000+ customers, from a wide range of industries, who have put their trust in us to help them grow their businesses." He adds, "We remain committed to helping our clients succeed by overcoming their logistical constraints as global supply chains become more complex in an ever-evolving business environment. We want to be our clients' growth partner, offering innovative, sustainable, and ethical logistics solutions, upheld by our values of passion, commitment, innovation, solidarity and trust – these are all in the GEODIS DNA." GEODIS employs over 450 employees in 20 sites in India. Hashtag: #GEODISThe issuer is solely responsible for the content of this announcement.GEODIS – www.geodis.com    GEODIS is a leading global logistics provider acknowledged for its expertise across all aspects of the supply chain. As a growth partner to its clients, GEODIS specializes in five lines of business: Supply Chain Optimization, Global Freight Forwarding, Global Contract Logistics, Distribution & Express, and European Road Network. With a global network spanning nearly 170 countries and more than 49,400 employees, GEODIS is ranked no. 6 in its sector across the world. In 2022, GEODIS generated €13.7 billion in revenue. GEODIS is a company owned by SNCF group.

文章來源 : Media OutReach Limited 發表時間 : 瀏覽次數 : 2528 加入收藏 :
Duopharma Biotech Applauded by Frost & Sullivan for Providing Innovative Healthcare Solutions in the Malaysian Market

Duopharma Biotech is a worldwide pioneer in the research and development of halal pharmaceuticals. SAN ANTONIO, July 25, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the Malaysian halal pharmaceutical industry and, based on its findings, recognizes Duopharma Biotech Berhad (Duopharma Biotech) with the 2022 Malaysian Company of the Year Award. Duopharma Biotech aims to produce safe, effective, and high-quality Halal products for all consumers and set the standard for the Malaysian pharmaceutical industry. Duopharma Biotech is expanding and improving its Halal portfolio to differentiate itself from competitors. Halal is an Arabic word that describes lawful or permissible products targeted at Muslim consumers. According to the State of Global Islamic Economy Report 2022, the Halal pharmaceutical market was valued at $100 billion in 2021 and is likely to reach $129 billion by 2025. As a result, Duopharma Biotech can benefit from the growing demand and is in a privileged position to fulfill the need for Halal pharmaceutical products. The company is expanding and improving its Halal portfolio to differentiate itself from competitors. It is the first pharmaceutical company to market a biosimilar erythropoietin, branded as ERYSAA®, a biosimilar product for treating anemia in chronic kidney disease. Duopharma Biotech designed this product to meet the health and wellness needs of the Malaysian population in a cost-effective manner that also complies with medical and Muslim standards. "As the world's first halal biosimilar, ERYSAA® secures Duopharma Biotech's leadership in the Halal pharmaceutical industry. In 2021, as physicians prescribed ERYSAA® to more dialysis patients, product sales grew by 52%. Despite the fierce competition from short and long-acting erythropoietin stimulating agents, ERYSAA® expanded into the dialysis market, with approximately 49% of dialysis centers and hospitals prescribing it to their renal anemia patients," said Dr. Maeirah Ashaie, Best Practices Research Consultant at Frost & Sullivan. Part of Duopharma Biotech Biotech's initiatives includes leading halal pharmaceutical awareness campaigns and exploring international collaborations to share halal-certified products. The company is building partnerships with international organizations to raise awareness of the importance of halal products to the Muslim population and is planning to expand to other markets, including the United Arab Emirates (UAE). Duopharma Biotech regularly conducts online surveys to ensure high customer service and quality standards and support its continued growth. As a result, the company scored 98% on the customer satisfaction index, higher than its previous two years' figures. "In 2021, the Halal Development Corporation Berhad (HDC) introduced a Sectoral Roadmap for halal pharmaceuticals to promote industry development. Duopharma Biotech is a member of the Sectoral Working Group, whose mission is to review and monitor the implementation of established measures. The company seeks to establish itself as a global thought leader in halal pharmaceuticals," noted Ashaie. Each year, Frost & Sullivan presents a Company of the Year award to the organization demonstrating excellence in growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies and the resulting leadership in customer value and market penetration. Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact:Tammy Chantammy.chan@frost.com About Duopharma  Duopharma Biotech Group ("Duopharma Biotech" or "the Company") began with the establishment of Duopharma (M) Sendirian Berhad in 1978. Duopharma Biotech was incorporated in 2000 and is today one of Malaysia's leading pharmaceutical companies listed on the Main Market of Bursa Malaysia Berhad. Duopharma Biotech has core competencies in the pharmaceutical industry inclusive of Manufacturing, Research & Development, and Commercialization & Marketing of over 300 generic drugs such as Crystorvas, Prelica, and Omesec as well as Consumer Healthcare ("CHC") products including CHAMPS®, FLAVETTES®, PROVITON®, and Uphamol, which are well-recognized and accepted by consumers in Malaysia, regionally and globally. The Company has also diversified into the biosimilars space with technology and commercialization collaborations with credible and strong international partners. ERYSAA®, Basalog One®, and Zuhera are a few commercialized biosimilar brands. Headquartered in Kuala Lumpur, Malaysia, Duopharma Biotech owns and operates three manufacturing plants in Klang, Bangi, and Glenmarie, Selangor. Duopharma Biotech also has subsidiary companies in the Philippines, Singapore and Indonesia. Website: www.duopharmabiotech.com

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 539 加入收藏 :
Moomoo marks new milestone with patented tech feature

U.S. Patent and Trademark Office awards patent for moomoo's charting tools SINGAPORE, July 25, 2023 /PRNewswire/ -- A recent survey on "Singapore Investors' Financial Resilience" sponsored by Moomoo Financial Singapore Pte. Ltd. ("Moomoo Singapore") revealed that savvy investors (8.3%) used advanced financial technology as an essential part of their investment process. This comes as the moomoo app was awarded a patent for its cutting-edge drawing and customization charts by the U.S. Patent and Trademark Office. Moomoo's line drawing tool is a technical analysis tool that allows technical traders to track movements of their target stocks and discover market trends.  Mr Gavin Chia, CEO of Moomoo Singapore, said: "This patent recognises Moomoo's constant quest to provide our clients with the necessary tools to help them in their trading journeys. Technology is at the core of everything we do, and our tech-driven capabilities will continue to be the unique proposition for our clients." The patented charting tools allow users to draw lines and shapes on charts, facilitating price movement analysis, pattern recognition, and identification of potential market opportunities from the convenience of their mobile devices —  anytime and anywhere. With 38 drawing tools and more than 60 technical indicators, as well as real-time data that updates every 0.03 seconds, the tool empowers users to create diverse charts to uncover potential trading opportunities and customise technical indicators for optimal investment decisions. "Technical trading used to be a full-time endeavour given its complex charting and need for multiple desktop monitors and the use of several monitors to keep track of multiple data points. Moomoo's line drawing tool is game-changer as it is mobile-friendly, which allows traders to conveniently utilise it on-the-go. It also supports more than six monitors simultaneously on one screen, providing traders with additional convenience," Chia said.  Seizing market opportunities An analysis of Moomoo's data highlighted the real-world applications of the charting tools to capture market opportunities. The use of charting tools to conduct technical analysis on U.S. stocks rose by 50% over the past month, according to data from Moomoo Technologies Inc. The upsurge reveals global investors actively captured the recent U.S. stocks upcycle, particularly in the tech giants. According to Moomoo data, the most viewed U.S. stocks in the past month were Tesla, Apple, Nvidia, Meta and Nio American depositary shares. Enagaging the community "In addition to our tech capabilities, Moomoo believes that education is the bedrock of every successful investment journey," Chia said. A series of online courses has been introduced on Moomoo's learning portal — Moo Learn — to educate users on drawing techniques for the charting tools. Novice investors are also encouraged to join Moomoo's interactive online community, where experienced investors actively share their insights on technical investing under various discussion topics. To engage with younger investors, Moomoo Singapore has engaged with several universities in Singapore as part of its education outreach programs. It is currently working with the Singapore Institute of Technology to conduct a study on the use of technology in promoting financial resilience and literacy. In addition, Moomoo has conducted paper trading competitions with several universities to raise awareness of trading techniques among the younger generation. "Moomoo Singapore will continue to leverage its data-driven approach to create ever greater value for our clients. We will continually upgrade and introduce new features to empower users with robust tools to navigate financial markets effectively, while pushing out more investor education programs to help our users in their investment journeys," Chia said. About Moomoo Singapore Moomoo Financial Singapore Pte. Ltd. (Moomoo Singapore) is an advanced financial technology company transforming the investing experience by offering a digitalised brokerage and wealth management platform – moomoo. Moomoo enhances the user experience with market data, news, and powerful analytical tools. Moomoo also embeds an unique digitalised investment community to connect all users, investors, companies, analysts, media and key opinion leaders. In Singapore, Moomoo Financial Singapore Pte. Ltd. (www.moomoo.com/sg) offers investment products for trading via the moomoo platform, and it is a capital markets services licence holder regulated by the Monetary Authority of Singapore (Licence No. CMS101000). In June 2022, Moomoo Singapore became the first digital brokerage to receive all five memberships from the SGX Group for the securities and derivatives markets.

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 865 加入收藏 :
2024 年 12 月 5 日 (星期四) 農曆十一月初五日
首 頁 我的收藏 搜 尋 新聞發佈